2Corey-Bollm J, Thai LJ, Calasko D, et al. Diagnosis and Evaluation of Dementia Neurology. Eur J Pharmacol 1995; 45:211.
3Sugawara T, Noshita N, Lewen A, et al. Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation. J Neurosci 2002; 22(1): 209-17.
4Sheng H, Brady TC, Pearlstein RD, et al. Extracellular superoxide dismutase deficiency worwens outcome from focal cerebral ischemia in the mouse. Neurosci Lett 1999;267(1): 13 -6.
5Frantseva MV, Carlen PL, Perez-Velazquez JL. Dynamics of intracellular calcium and free radical production during ischemia in pyramidal neurons. Free Radic Biol Med 2001;31(lO): 1216-27.
6Matsuda T, Arakawa N, Takuma K, et al. SEA0400, a novel and selective inhibitor of the Na^2+ -Ca^2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. J Pharmacol Exp Ther 2001 ; 298 ( 1 ) : 249 - 56.
7Overgaard K, Sereghy T, Pedersen H, et al. Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model. J Cereb Blood Flow Metab 1997; 17(5): 596.
8Black S, Roman GC, Geldmacher DS, et al. Efficacy and tolerability of donopezil in vascilar dementia: positive results of a 24-week, multicenter, international,randomized, placebo-controlled clinical trial. Stroke 2002; 34( 10): 2323 -30.
9Roman GC, Erkinjutti T, Wallin A, et al. Subcortical ischaemic vascular dimintia. Lancer Neurol 2002; 1 (7): 426 - 36.
10Erkinjuntti T, lnzitari DmPantoni L, et al. Research criteria for subcortical vascular dementia in clinical trials. J Transm Suool 2000; 59:23 - 30.
